Anticholinergic drug exposure is associated with prevalence, worsening and incidence of dysphagia among hospitalized older adults - 14/02/25

Doi : 10.1016/j.jnha.2025.100507 
Lucia Muglia a, 1 , Alessia Beccacece b, 1 , Luca Soraci c, , Ramona Caloiero c , Franco Arturi d , Paolo Fabbietti b , Mirko Di Rosa b , Jacopo Sabbatinelli e, f , Giada Ida Greco c , Elvira Filicetti c , Mara Volpentesta c , Alberto Montesanto g , Ersilia Paparazzo a, g , Antonio Cherubini e, h , Massimiliano Fedecostante e , Chiara Chinigò a , Maria Capalbo i , Andrea Corsonello c, j, 2 , Fabrizia Lattanzio k, 2
a Centre for Biostatistics and Applied Geriatric Clinical Epidemiology, Italian National Research Center on Aging (IRCCS INRCA), Cosenza, Italy 
b Centre for Biostatistics and Applied Geriatric Clinical Epidemiology, Italian National Research Center on Aging (IRCCS INRCA), Ancona, Italy 
c Unit of Geriatric Medicine, Italian National Research Center on Aging (IRCCS INRCA), Cosenza, Italy 
d Department of Medical and Surgical Sciences, University "Magna Graecia" Medical School, Internal Medicine Unit, Outpatient Unit for the Treatment of Obesity, University Hospital "R. Dulbecco", 88100 Catanzaro, Italy 
e Department of Clinical and Molecular Sciences, Università Politecnica Delle Marche, Ancona, Italy 
f Clinic of Laboratory and Precision Medicine, IRCCS INRCA, Ancona, Italy 
g Department of Biology, Ecology and Earth Sciences, University of Calabria, Arcavacata di Rende, Italy 
h Geriatria, Accettazione Geriatrica e Centro di Ricerca Per L’invecchiamento, IRCCS INRCA, Ancona, Italy 
i General Direction, IRCCS INRCA, Ancona, Italy 
j Department of Pharmacy, Health and Nutritional Sciences, School of Medicine and Digital Technologies, University of Calabria, Arcavacata di Rende, Italy 
k Scientific Direction, IRCCS INRCA, Ancona, Italy 

Corresponding author.

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Highlights

This study aims to assess the impact of medium-to-high anticholinergic burden on the risk of dysphagia among an unselected population of hospitalized older individuals
Both CALS and ACB anticholinergic burden scales were significantly associated with the prevalence, worsening, and incidence of dysphagia among hospitalized older adults.
The findings support the need for regular medication review to reduce anticholinergic medication use in older adults to mitigate the risk of dysphagia and related complications.

Le texte complet de cet article est disponible en PDF.

Abstract

Objectives

In this study, we aimed at evaluating the association between anticholinergic drug exposure and prevalence, worsening, and incidence of dysphagia among hospitalized older individuals.

Design and setting

We used data from the REPORT-Age project, a multicenter cohort study including patients aged 65 years or more, admitted to acute care hospitals of the Italian National Institute for Health and Sciences on Aging (INRCA-IRCCS) between 2011 and 2019.

Participants

4,005 older patients aged 84.7 (SD = 6.6) years underwent comprehensive geriatric examination according to the interRAI minimum dataset for acute care (MDS-AC), at both hospital admission and discharge.

Measurements

Both prevalence and severity of dysphagia were assessed through items of subjective evaluation included in the section K3 of MDS-AC questionnaire; the anticholinergic drug exposure was measured by means of CRIDECO Anticholinergic Load Scale (CALS) and Anticholinergic Cognitive Burden (ACB) scales. Next, we used logistic regression models to evaluate the association between anticholinergic burden and prevalence of dysphagia at hospital admission; Kaplan Meier cumulative probability curves and cox proportional hazard models were used to analyze the association between anticholinergic burden at hospital admission and worsening or incidence of dysphagia during hospital stay.

Results

Out of 4,005 patients included, 1,070 (30%) presented dysphagia at hospital admission. High anticholinergic burden was associated with increased prevalence of dysphagia at hospital admission (p < 0.001). Moreover, patients with high anticholinergic burden (ACB and CALS ≥ 2) were at increased risk of dysphagia worsening during hospital stay (HR, 95%CI: 1.14, 1.06−1.22 and 1.12, 1.03−1.23 for ACB and CALS respectively). Among the 2,935 patients with normal swallowing function at hospital admission, high anticholinergic burden was associated with the incidence of dysphagia at hospital discharge (HR, 95% CI: 1.89, 1.21−2.96 and 1.86, 1.14−3.06 for ACB and CALS respectively). Development of dysphagia during hospital stay was associated with a reduced prescription of anticholinergic medications (ORs, 95% CI 1.13 (1.07–1.20) and 1.08 (1.01–1.15) for ACB and CALS, respectively).

Conclusions

Increased anticholinergic burden was associated with the prevalence, worsening, and incidence of dysphagia among older hospitalized patients.

Le texte complet de cet article est disponible en PDF.

Keywords : Dysphagia, Anticholinergic, Older, CALS, ACB.

Abbreviations : ACB, AF, ATC, BADL, CAD, CALS, CGA, CKD, CI, COPD, CPS, HF, HR, ICD, MDS-AC, OR


Plan


© 2025  The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 29 - N° 5

Article 100507- mai 2025 Retour au numéro
Article précédent Article précédent
  • CUN-BAE adiposity index prediction of incident type 2 diabetes: the Seguimiento Universidad de Navarra prospective cohort
  • Ligia J. Dominguez, Carmen Sayón-Orea, Alfredo Gea, Estefania Toledo-Atucha, Maira Bes-Rastrollo, Mario Barbagallo, Miguel A. Martínez-González
| Article suivant Article suivant
  • Incidence of dysphagia-related safety incidents in older adults across feeding methods: A systematic review and meta-analysis
  • Yingying Zhang, Zhina Gong, Jianzheng Cai, Weixia Yu, Yinuo Dai, Haifang Wang

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.